CAS: 30992-69-9 - 7-benzyloxy-4-hydroxy-3-(3-oxo-1-phenyl-butyl)chromen-2-one
Formula:C26H22O5
InChI:InChI=1S/C26H22O5/c1-17(27)14-22(19-10-6-3-7-11-19)24-25(28)21-13-12-20(15-23(21)31-26(24)29)30-16-18-8-4-2-5-9-18/h2-13,15,22,28H,14,16H2,1H3
InChI key:InChIKey=VWMPIXQSCDHVKC-UHFFFAOYSA-N
SMILES:O=C1OC=2C=C(OCC=3C=CC=CC3)C=CC2C(O)=C1C(C=4C=CC=CC4)CC(=O)C
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-7-(phenylmethoxy)- REF: IN-DA0031VGCAS: 30992-69-9 | - - - | To inquire | Thu 02 Jan 25 |
 | (S)-7-Benzyloxy Warfarin REF: TR-B288565CAS: 30992-69-9 | - - - | 5,339.00 € | Tue 11 Feb 25 |
| (S)-7-Benzyloxy Warfarin Quinidine Salt REF: TR-B288540CAS: | - - - | 3,559.00 € | Tue 11 Feb 25 |
 | 7-Benzyloxy warfarin REF: 3D-FB18415CAS: 30992-69-9 | Min. 95% | - - - | Discontinued product |
2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-7-(phenylmethoxy)-
CAS:30992-69-9
Formula:
C26H22O5
Color and Shape:
Solid
Molecular weight:
414.4499
Ref: IN-DA0031VG
| Undefined size | To inquire |
Estimated delivery in United States, on Thursday 2 Jan 2025
(S)-7-Benzyloxy Warfarin
Controlled ProductCAS:30992-69-9
Formula:
C26H22O5
Color and Shape:
Neat
Molecular weight:
414.45
Ref: TR-B288565
| 100mg | 5,339.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
(S)-7-Benzyloxy Warfarin Quinidine Salt
Controlled ProductFormula:
C26H22O5·C20H24N2O2
Color and Shape:
Neat
Molecular weight:
738.867
Ref: TR-B288540
| 100mg | 3,559.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
7-Benzyloxy warfarin
CAS:30992-69-9
Please enquire for more information about 7-Benzyloxy warfarin including the price, delivery time and more …
Formula:
C26H22O5
Purity:
Min. 95%
Molecular weight:
414.45 g/mol
Ref: 3D-FB18415
| 2mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information |
